2m 2m 2m 2m 2m 2m 2m
EDGEWISE THERAP (EWTX)
NASDAQ
$38.37+$1.87 (+5.12%)
Price as of Jun 23, 2026 7:47 PM EDT- $3.9BMarket Cap
- 157.40%1-Year Change
- BiotechnologyIndustry
EDGEWISE THERAP (EWTX)
$38.37+$1.87 (+5.12%)
EWTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $36.50 | ||
Change | -$0.31 (-0.84%) | ||
Open | $37.51 | ||
High | $37.51 | ||
Low | $35.96 | ||
Previous Close | $36.81 | ||
Volume | 1,158,464 | ||
30-Day Average Volume | 1,949,560 | ||
1-Week Change | 3.66% | ||
1-Month Change | 11.62% | ||
1-Year Change | 157.40% | ||
3-Year Change | 366.16% | ||
5-Year Change | 38.99% | ||
Fundamentals | |||
Shares Outstanding | 107.6M | ||
Total Assets | $518.5M | ||
Market Cap | $3.9B | ||
Enterprise Value | $3.9B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$49.0M | ||
Free Cash Flow | -$42.8M | ||
EBIT | -$49.0M | ||
EBITDA | -$48.5M | ||
Net Working Capital | $487.2M | ||
EPS | -$0.46 | ||
Enterprise Value/EBITDA | -80 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 8 | ||
P/E | -79 | ||
PEG | -27 | ||
Price/Free Cash Flow | -92 | ||
Price/Operating Cash Flow | -92 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue